Acid lock could fight blood infections in cancer patients
NCT ID NCT05376566
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a hydrochloric acid lock can help treat central line infections in 212 cancer and blood disease patients. The acid solution was placed in the line for 10 minutes, repeated three times, alongside standard antibiotics. The goal was to see if it reduces treatment failure, including persistent infection or the need to remove the line.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hydrochloric acid (2 M) lock solution
What this could lead to
If it works, this could provide a simple, low-cost way to treat central line infections in cancer patients, potentially reducing the need to remove the line.
What could go wrong
This is a completed trial, but the intervention is a strong acid that must be used carefully. It may not work better than standard care, and results may not apply to all patient groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Haematology, Copenhagen University Hospital
Copenhagen, 2100, Denmark
-
Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital
Aarhus, 3200, Denmark
-
Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital
Copenhagen, 2100, Denmark
-
Department of Paediatrics and Adolescent Medicine, Odense University Hospital
Odense, 4000, Denmark